UTHR or CTLT: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Catalent (CTLT) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Currently, United Therapeutics has a Zacks Rank of #2 (Buy), while Catalent has a Zacks Rank of #5 (Strong Sell). This means that UTHR's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analys ...